Tenaya Therapeutics to Participate in Upcoming Piper Sandler 34th Annual Healthcare Conference
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company focused on therapies for heart disease, will present at the Piper Sandler 34th Annual Healthcare Conference in New York from November 29 to December 1, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company focused on therapies for heart disease, will present at the Piper Sandler 34th Annual Healthcare Conference in New York from November 29 to December 1, 2022. The company will participate in a panel discussion titled 'Heart to Heart with CV Players to Discuss 2023 Outlook' on November 29 at 2:30 p.m. ET and a fireside chat on November 30 at 8:30 a.m. ET. A webcast of the event can be accessed on Tenaya’s website, with a replay available for 30 days after.
Details
News Market Reaction – TNYA
The recorded move for TNYA in the trading session of this news was -4.31%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Tenaya management will participate in the Piper Sandler 34th Annual Healthcare Conference, taking place in New York, NY, from November 29th to December 1st.
Details of Tenaya’s participation are as follows:
Panel Discussion: Heart to Heart with CV Players to Discuss 2023 Outlook
Date: November 29, 2022
Time: 2:30 – 3:25 p.m. ET
Fireside Chat
Date: November 30, 2022
Time: 8:30 – 8:55 a.m. ET
A webcast of the Piper Sandler event will be available by visiting the Investors section of Tenaya’s website. A replay of the webcast will be available on the Tenaya website for approximately 30 days following the conference.
About Tenaya Therapeutics
Tenaya Therapeutics is a clinical-stage biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic cardiovascular disorders, as well as for more prevalent heart conditions, through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. For more information, visit www.tenayatherapeutics.com.
| Contacts | ||
| Investors Michelle Corral Vice President, Investor Relations and Corporate Communications Tenaya Therapeutics IR@tenayathera.com | Media Wendy Ryan Ten Bridge Communications wendy@tenbridgecommunications.com | |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.